2655174
SBDFP · Branded drug packinfluenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza A virus A/Victoria/2570/2019 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere]
Concept
Cross-maps
Synonyms
No additional synonyms recorded.
Related concepts
Common questions
What is the RxNorm code for influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza A virus A/Victoria/2570/2019 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere]?
influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza A virus A/Victoria/2570/2019 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere] is coded as 2655174 in RxNorm.
What is RxNorm code 2655174?
2655174 is the RxNorm identifier for influenza A virus A/Hong Kong/2671/2019 (H3N2) antigen / influenza A virus A/Victoria/2570/2019 (H1N1) antigen / influenza B virus B/Phuket/3073/2013 antigen / influenza B virus B/Washington/02/2019 antigen Injectable Suspension [Fluzone Quadrivalent 2021 Southern Hemisphere]. It is included in the current monthly NLM RxNorm release.
What term type is RxCUI 2655174?
2655174 is a SBDFP (Branded drug pack) in RxNorm.
What is the UMLS mapping for 2655174?
2655174 maps to UMLS C5839039.